This is a routine proxy filing with no material financial information. Traders should monitor for the upcoming shareholder meeting where voting on director elections and executive compensation will occur, but no immediate trading action is warranted based on this filing.
Price Chart
Executive Summary
Amneal Pharmaceuticals, Inc. (AMRX) has filed a definitive proxy statement (DEFA14A) related to a shareholder vote. The document is filed by the registrant (Amneal Pharmaceuticals) and is a definitive additional proxy soliciting material. The filing provides information about matters to be voted on by shareholders, including director elections, executive compensation, and other corporate governance issues. The document is part of the proxy solicitation process leading up to the company's annual meeting.
Key Facts
- Company: Amneal Pharmaceuticals, Inc. (AMRX)
- Form Type: DEFA14A (Definitive Additional Proxy Soliciting Materials)
- Filed by: The Registrant (Amneal Pharmaceuticals)
- Document Type: Definitive Additional Materials
- Purpose: Proxy solicitation for shareholder vote
- Filing Date: 2026-03-25
- No financial data or material business changes disclosed in the provided documents
Financial Impact
No financial impact disclosed
Risk Factors
- Potential shareholder activism or voting outcomes at the annual meeting could impact governance, though not indicated in this filing
- Executive compensation packages could affect investor sentiment if perceived as excessive
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001308179-26-000144 |
| Document: 0001308179-26-000144-index-headers.html | 0001308179-26-000144 |
| Document: 0001308179-26-000144-index.html | 0001308179-26-000144 |
| Document: 0001308179-26-000144.txt | 0001308179-26-000144 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K/A | $21.02 | awaiting T+60 | — | $21.44 (+2.00%) |
Sep 18, 2026 5w ago | Press Release | $20.16 | awaiting T+60 | — | $21.44 (+6.35%) |
Aug 16, 2026 10w ago | Institutional Cluster | $18.42 | awaiting T+60 | — | $21.44 (+16.40%) |
Aug 14, 2026 10w ago | Insider Cluster | $18.42 | awaiting T+60 | — | $21.44 (+16.40%) |
Aug 13, 2026 10w ago | Insider Cluster | $18.15 | awaiting T+60 | — | $21.44 (−18.13%) |
Aug 10, 2026 11w ago | 8-K | $17.10 | awaiting T+60 | — | $21.44 (+25.38%) |
Jul 30, 2026 12w ago | DEFA14A | $18.50 $20.38 | ▲ +10.16% | ▲ +7.70% | $21.44 (+15.89%) |
Jul 17, 2026 14w ago | Press Release | $17.85 $20.03 | ▲ +12.21% | ▲ +7.53% | $21.44 (+20.11%) |
Jun 29, 2026 17w ago | DEFM14A | $17.29 $19.50 | ▲ +12.78% | ▲ +8.40% | $21.44 (+24.00%) |
Jun 29, 2026 17w ago | Press Release | $17.29 $19.50 | ▲ +12.78% | ▲ +8.40% | $21.44 (+24.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers